1. Home
  2. BOLD vs EPOW Comparison

BOLD vs EPOW Comparison

Compare BOLD & EPOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • EPOW
  • Stock Information
  • Founded
  • BOLD 2018
  • EPOW 2014
  • Country
  • BOLD United States
  • EPOW China
  • Employees
  • BOLD N/A
  • EPOW N/A
  • Industry
  • BOLD
  • EPOW Business Services
  • Sector
  • BOLD
  • EPOW Consumer Discretionary
  • Exchange
  • BOLD Nasdaq
  • EPOW Nasdaq
  • Market Cap
  • BOLD 24.4M
  • EPOW 24.8M
  • IPO Year
  • BOLD 2024
  • EPOW 2021
  • Fundamental
  • Price
  • BOLD $1.19
  • EPOW $0.90
  • Analyst Decision
  • BOLD Buy
  • EPOW
  • Analyst Count
  • BOLD 3
  • EPOW 0
  • Target Price
  • BOLD $4.00
  • EPOW N/A
  • AVG Volume (30 Days)
  • BOLD 105.1K
  • EPOW 16.4K
  • Earning Date
  • BOLD 08-11-2025
  • EPOW 08-05-2025
  • Dividend Yield
  • BOLD N/A
  • EPOW N/A
  • EPS Growth
  • BOLD N/A
  • EPOW N/A
  • EPS
  • BOLD N/A
  • EPOW N/A
  • Revenue
  • BOLD N/A
  • EPOW $64,997,741.00
  • Revenue This Year
  • BOLD N/A
  • EPOW N/A
  • Revenue Next Year
  • BOLD N/A
  • EPOW N/A
  • P/E Ratio
  • BOLD N/A
  • EPOW N/A
  • Revenue Growth
  • BOLD N/A
  • EPOW 44.28
  • 52 Week Low
  • BOLD $1.00
  • EPOW $0.55
  • 52 Week High
  • BOLD $4.72
  • EPOW $1.36
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • EPOW 46.09
  • Support Level
  • BOLD N/A
  • EPOW $0.87
  • Resistance Level
  • BOLD N/A
  • EPOW $0.95
  • Average True Range (ATR)
  • BOLD 0.00
  • EPOW 0.04
  • MACD
  • BOLD 0.00
  • EPOW -0.00
  • Stochastic Oscillator
  • BOLD 0.00
  • EPOW 19.54

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About EPOW Sunrise New Energy Co. Ltd

Sunrise New Energy Co Ltd is engaged in the manufacturing and sale of graphite anode material for EVs and other lithium-ion batteries. The Company's joint venture is in the construction of a manufacturing plant in Guizhou Province. The plant runs on inexpensive electricity from renewable sources that enables the group to be a low-cost and low environmental impact producer of graphite anode material, Its products include GS-1, GS-2, GS-3, GZD-1, GLD-1, and GZ-1.

Share on Social Networks: